Table 1.
Changes in Cognitive and Functional Performance from Pre-Chemotherapy to Post-Chemotherapy Assessment Assessed by the Reliable Change Index.
| Measure | Chemotherapy, n (%) |
No chemotherapy, n (%) |
Odds Ratio* Decline vs. Same and Improve (95% CI) |
p-value* |
|---|---|---|---|---|
| UFOV (n=69) | 1.72 (0.37-7.84) | .4824 | ||
| Improve | 2 (5.71) | 5 (14.71) | ||
| Same | 28 (80.00) | 26 (76.47) | ||
| Decline | 5 (14.29) | 3 (8.82) | ||
| RST (n=73) | 1.61 (0.50-5.09) | .4205 | ||
| Improve | 3 (8.11) | 8 (22.22) | ||
| Same | 25 (67.57) | 22 (61.11) | ||
| Decline | 9 (24.32) | 6 (16.67) | ||
| Digit Symbol (n=73) | 3.29 (0.62-17.52) | .1629 | ||
| Improve | 2 (5.41) | 5 (13.89) | ||
| Same | 29 (78.38) | 29 (80.56) | ||
| Decline | 6 (16.22) | 2 (5.56) | ||
| TIADL (n=73) | 1.61 (0.50-5.09) | .4205 | ||
| Improve | 1 (2.70) | 7 (19.44) | ||
| Same | 27 (72.97) | 23 (63.89) | ||
| Decline | 9 (24.32) | 6 (16.67) |
*
Odds ratio and p-value were computed using logistic regression analyses with dichotomous outcomes (decline=1 vs. no decline =0) and group as the only predictor.